Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...

Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...

Phrasing is "anything but objective," former Journal of the American Medical Association deputy editor says. Harvard-led ...

Respiratory virus season is upon the United States as the cold weather months set in, meaning cases of COVID-19, influenza and RSV are set to increase. In its annual outlook report, the Centers for ...

There were 176.6 major congenital malformations (MCMs) per 10,000 infants exposed to first-trimester COVID-19 mRNA vaccines, compared with 179.4 per 10,000 infants not exposed to the vaccines. There ...

Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...

Add Yahoo as a preferred source to see more of our stories on Google. The Covid jab helped cancer patients survive longer, scientists believe, opening the door for a universal vaccine to boost the ...